|
Characteristic
|
All patients (n = 51)
|
Status 6 months post-ICU
|
Pvalue
|
|---|
| |
Alive (n = 28)
|
Dead (n = 23)
|
|---|
|
Age (years)
|
48 (33-58)
|
42 (31-53)
|
56 (38-60)
|
0.05
|
|
Men
|
27 (53)
|
16 (57)
|
11 (48)
|
0.35
|
|
Body mass index (kg/m2)
|
25 (22-29)
|
26 (23-29)
|
24 (20-32)
|
0.36
|
|
Charlson score
|
2 (1-4)
|
1 (1-4)
|
4 (2-5)
|
0.03
|
|
SAPS II
|
48 (30-61)
|
43 (29-56)
|
51 (39-67)
|
0.09
|
|
SOFA score
|
12 (9-13)
|
11 (9-13)
|
12 (9-15)
|
0.09
|
|
Chronic lung disease
|
8 (16)
|
4 (14)
|
4 (17)
|
0.76
|
|
Pregnant or postpartum
|
0 (0)
|
0 (0)
|
0 (0)
|
1.0
|
|
Diabetes mellitus
|
7 (14)
|
3 (11)
|
4 (17)
|
0.69
|
|
Renal insufficiency
|
4 (8)
|
3 (11)
|
1 (4)
|
0.62
|
|
Immunocompromiseda
|
17 (33)
|
7 (25)
|
10 (44)
|
0.23
|
|
Hematological malignancies
|
4 (8)
|
3 (11)
|
1 (4)
|
0.32
|
|
Solid tumor
|
4 (8)
|
1 (4)
|
3 (13)
|
0.32
|
|
Solid organ transplantation
|
3 (6)
|
2 (7)
|
1 (4)
|
0.67
|
|
High-dose or long-term CS/IS
|
9 (18)
|
4 (14)
|
5 (22)
|
0.49
|
|
HIV
|
3 (6)
|
2 (7)
|
1 (4)
|
0.67
|
|
ARDS etiology
| | | |
0.27
|
|
Peri-/postoperative
|
5 (10)
|
3 (11)
|
2 (9)
| |
|
Influenza A H1N1
|
8 (16)
|
2 (7)
|
6 (26)
| |
|
Influenza other
|
7 (14)
|
3 (11)
|
4 (17)
| |
|
Bacterial infection
|
21 (41)
|
13 (47)
|
8 (35)
| |
|
Primary ARDS
|
8 (16)
|
5 (18)
|
3 (13)
| |
|
Others
|
3 (6)
|
2 (7)
|
1 (4)
| |
- Values are expressed as median (interquartile range) or n (%). aImmuncompromised status included hematological malignancies, solid tumors, solid-organ transplantation, high-dose or long-term corticosteroids and/or immunosuppressant use, or HIV infection. ARDS, acute respiratory disease syndrome; CS/IS, corticosteroids or immunosuppressants; ECMO, extracorporeal membrane oxygenation; SAPS, simplified acute physiology score; SOFA, sepsis-related organ failure assessment.
